Brief: Galenica Increases Sales Growth In The Third Quarter

Galenica AG

24/10/2024 05:49

Oct 24 (Reuters) - GALENICA AG  GALE.S :
    * INCREASES SALES GROWTH IN THE THIRD QUARTER
    * Q3 NET SALES OF CHF 2,864.8 MILLION TO END OF SEPTEMBER
2024
    * NEGATIVE IMPACT OF MISSING SALES DAY AT END OF JUNE WHICH
WAS
ESTIMATED TO BE -0.8% COMPARED WITH PRIOR-YEAR PERIOD, HAS BEEN
OFFSET BY END OF SEPTEMBER
    * 2024 OUTLOOK CONFIRMED
    * SIGNIFICANT ADDITIONAL SALES OF GENERICS AND BIOSIMILARS
CONTINUED TO DAMPEN GROWTH
    * GENERIC SUBSTITUTION RATE OF GALENICA PHARMACIES
STABILISED AT A
HIGH 80.3% AT END OF SEPTEMBER COMPARED TO MIDDLE OF YEAR (80.8%
AT END OF JUNE 2024)

Source text for Eikon:  ID:nEQb5YVYba 
Further company coverage:  GALE.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))